Want to know if this job is worth applying to?
Melbourne, Victoria, Australia
Onsite
At CSL, our Research & Development team is dedicated to advancing innovative therapies that improve the lives of patients worldwide. We are seeking an enthusiastic Associate Scientist to join our Nonclinical Pharmacology Group in Melbourne and contribute to the discovery and development of next-generation biologic therapies.
In this role, you will support a diverse portfolio of projects focused on understanding the mechanisms of action of novel therapeutics, including recombinant antibodies and other protein-based medicines. Working in a collaborative research environment, you will help design and execute in vivo, in vitro, and ex vivo studies that provide critical proof-of-concept and proof-of-mechanism data to drive drug development programs forward.
Reporting to the Senior Manager, Nonclinical Pharmacology, you will play a key role in generating high-quality scientific data while contributing to the ongoing success of CSL’s research programs.
You are a motivated and detail-oriented scientist with a strong background in immunology, biological sciences, or a related field. You enjoy working in a collaborative environment, have a passion for translational research, and are eager to contribute to the development of innovative therapies.
At CSL, you'll be part of a global biotechnology leader committed to saving lives and protecting the health of people around the world. You'll have the opportunity to work alongside leading scientists, access cutting-edge technologies, and contribute to research that has a meaningful impact on patients.
If you are passionate about scientific discovery and want to help develop tomorrow's therapies, we encourage you to apply.
Applications Close on November 8th 2026
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
